1.
Mov Disord
; 17(1): 188-91, 2002 01.
Article
in English
| MEDLINE
| ID: mdl-11835461
ABSTRACT
Twelve patients with levodopa-induced dyskinesias were treated with continuous subcutaneous apomorphine. A markedly significant reduction in peak dose dyskinesias occurred over a two-year follow-up.